Distributing since 1889 • Employee Owned for Better Service
Your 1st Choice!
Sign In
Quick Search:

Shopping Cart Cart |  My Account |  View Printable Page Print
Product Detail

Martindale: The Complete Drug Reference. 2 Volume Boxed Set

Brayfield, Akison
Martindale: The Complete Drug Reference. 2 Volume Boxed Set Cover Image
Pricing & Availability
Available: 0
List Price:$850.00

Email this title to a friend Email this title to a friend
Printer friendly version Printer friendly version
Book Information
Edition: 41th
Publisher: Pharmaceutical Press
ISBN: 0-85711-484-0 (0857114840)
ISBN-13: 978-0-85711-484-6 (9780857114846)
Old Edition: 0-85711-367-4
Format: British
Binding: Hardcover
Copyright: 2024
Publish Date: 06/24
Weight: 14.94 Lbs.
Pages: 4800
Subject Class: PRM (Pharmacology)
Return Policy: Returns accepted up to 12 months provided no other recalls or return restrictions apply.
Contributing Authors: View
 
Class Specifications
ISSN Series: Martindale: The Complete Drug Reference
Discipline: Pharmacology
Subject Definition: Pharmacopoeias as Topic-Great Britain; Pharmaceutical Prep
NLM Class: QV 738
LC Class: RS139
Abstract: Martindale: The Complete Drug Reference provides unbiased, evaluated information on drugs and medicines in use around the world. It remains the leading international resource, respected for its objectivity, reliability and global coverage.It's unique offering includes encyclopaedic facts about drugs and medicines.New for the 41st Edition - Over 130 monographs including:New antivirals such as fostemsavir and lenacapavir for multi-drug resistant HIV infection and bulevirtide for hepatitis D New biological treatments for type 1 diabetes (teplizumab), non-neovascular (dry) age-related macular degeneration (pegcetacoplan), and spinal muscle atrophy type 1 (onasemnogene abeparvovec) New class of drugs for migraine management: the calcitonin gene-related peptide (CGRP) receptor antagonists atogepant, rimegepant, ubrogepant, and zavegepant New content on management of COVID-19 including a new disease treatment review, COVID-19 infections, new monographs for the antivirals molnupiravir, nirmatrelvir, and remdesivir, and for COVID-19 vaccines, and updates to uses of baricitinib and tocilizumab Updated content on malaria and dengue vaccines

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2025 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement